NCT05538663 2026-03-02
BRIDGE
Eastern Cooperative Oncology Group
Phase 3 Active not recruiting
Clinical Trials
7 trialsNCT00352079 2023-08-04
BCG With or Without Gefitinib in Treating Patients With High-Risk Bladder Cancer
Canadian Cancer Trials Group
Phase 3 Terminated
NCT00002990 2013-06-12
Surgery and BCG in Treating Patients With Bladder Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3 Completed
NCT00003386 2013-04-11
Vaccine Therapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer
GOG Foundation
Phase 2 Terminated
NCT00023842 2012-09-24
BCG With or Without Mitomycin in Treating Patients With Bladder Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Completed
NCT00006352 2012-07-18
Monoclonal Antibody Therapy Plus BCG in Treating Patients With Limited-Stage Small Cell Lung Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3 Completed
NCT00003279 2012-03-06
SILVA
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3 Completed